T. Rowe Price Investment Management, Inc. Elanco Animal Health Inc Transaction History
T. Rowe Price Investment Management, Inc.
- $162 Billion
- Q4 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Elanco Animal Health Inc stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 15,690,736 shares of ELAN stock, worth $175 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
15,690,736
Previous 21,042,806
25.43%
Holding current value
$175 Million
Previous $309 Million
38.53%
% of portfolio
0.12%
Previous 0.19%
Shares
6 transactions
Others Institutions Holding ELAN
# of Institutions
438Shares Held
448MCall Options Held
1.16MPut Options Held
1.12M-
Dodge & Cox San Francisco, CA83.2MShares$926 Million0.63% of portfolio
-
Primecap Management CO Pasadena, CA51.2MShares$569 Million0.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA48.8MShares$543 Million0.01% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$259 Million0.01% of portfolio
-
Black Creek Investment Management Inc. Toronto, A620.4MShares$227 Million11.79% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $5.28B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...